New Triple-Target cancer drug enters first human trials
NCT ID NCT06598800
Summary
This is the first study in people testing a new experimental drug called BG-T187 for advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help shrink tumors. The drug will be tested both by itself and in combination with other cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Asan Medical Center
RECRUITINGSongpaGu, Seoul Teugbyeolsi, 05505, South Korea
-
Blacktown Cancer and Haematology Centre
RECRUITINGBlacktown, New South Wales, NSW 2148, Australia
-
Cabrini Hospital Malvern
RECRUITINGMalvern East, Victoria, VIC 3144, Australia
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, 400030, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, Guangxi, 530021, China
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601-1915, United States
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, Heilongjiang, 150000, China
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430079, China
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, WA 6009, Australia
-
Linyi Peoples Hospital
RECRUITINGLinyi, Shandong, 276000, China
-
Macquarie University
RECRUITINGNorth Ryde, New South Wales, NSW 2109, Australia
-
Next Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Samsung Medical Center
RECRUITINGGangnamGu, Seoul Teugbyeolsi, 06351, South Korea
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggi-do, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
Severance Hospital Yonsei University Health System
RECRUITINGSeodaemunGu, Seoul Teugbyeolsi, 03722, South Korea
-
The Catholic University of Korea, Seoul St Marys Hospital
RECRUITINGSeochoGu, Seoul Teugbyeolsi, 06591, South Korea
-
The Catholic University of Korea, St Vincents Hospital
RECRUITINGPaldalGu SuwonSi, Gyeonggi-do, 16247, South Korea
-
The First Affiliated Hospital, Zhejiang University School of Medicinezhijiang Branch
RECRUITINGHangzhou, Zhejiang, 310024, China
-
The Sixth Affiliated Hospital, Sun Yat Sen University
RECRUITINGGuangzhou, Guangdong, 510655, China
-
The University of Texas Md Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4009, United States
-
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGTianjin, Tianjin Municipality, 300060, China
-
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
-
Washington University, St Louis, Division of Oncology
RECRUITINGMadison, Wisconsin, 53708-8056, United States
Conditions
Explore the condition pages connected to this study.